Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581815 · ClinicalTrials.gov registry record · Phase 1
Spectroscopy With Surface Coils and Decoupling
A Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 582
- Enrollment target
NCT00581815: Completed Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00581815 is a Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 582 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (870% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00581815, a Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 582 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain chemical information from part of your body without a biopsy. This is done using a technique called magnetic resonance spectroscopy (MRS) which is similar to magnetic resonance imaging (MRI) except that signals are detected from the chemicals (spectroscopy) naturally present in your body using radio waves. To receive this information from your body, small loops of wire (surface coils), placed near the tissue of interest, may be used to more effectively detect signals that come from the chemicals in your body. The investigators may use a second radio channel simultaneously, which will allow us to obtain greater chemical information (decoupling). The results may also help us to understand how this study can be used to help other patients with your condition.
Interventions
- DEVICE Proton-decoupled 31P MRS at 1.5T
- DEVICE 1H Spectroscopy at 1.5T and 3T
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 582 participants |
| Start Date | 1997-02 |
| Est. Completion | 2014-02 |
| Phase | Phase 1 |
What the finished NCT00581815 record still lists
NCT00581815 is an interventional study that assigns participants to a tested intervention. The registered 582 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (870% higher).
The record links to 0 conditions, and to 2 interventions - of which Proton-decoupled 31P MRS at 1.5T is the first listed.
NCT00581815 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00581815 about?
NCT00581815 is a clinical study titled "Spectroscopy With Surface Coils and Decoupling". The purpose of this study is to obtain chemical information from part of your body without a biopsy. This is done using a technique called magnetic resonance spectroscopy (MRS) which is similar to magnetic resonance imaging (MRI) except that signals are detected from the chemicals (spectroscopy) nat...
What is the current status of trial NCT00581815?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 582 participants. The study started on 1997-02. Estimated completion is 2014-02.
What interventions are being tested in trial NCT00581815?
The interventions under investigation include: Proton-decoupled 31P MRS at 1.5T (DEVICE), 1H Spectroscopy at 1.5T and 3T (DEVICE).
Who is sponsoring clinical trial NCT00581815?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00581815's enrollment target sits among peer trials
582 32nd of 2000 higher than 1,969 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06350097 · 582 participants · Phase 3
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
- NCT06563895 · 582 participants · Phase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- NCT06819007 · 582 participants · Phase 3
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- NCT03840083 · 584 participants · NA
Sleep-dependent Learning in Aging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia